Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Targeting the DNA damage response

Thomas Helleday, MD, PhD, Karolinska Institute, Stockholm, Sweden & University of Sheffield, Sheffield, UK, discusses DNA repair, including research on the SPRTN/DVC1 enzyme, oncogene-induced replication stress, and targeting DNA damage response. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.